It is a genetic condition with an expected incidence in the UK of 1.8 per 100,000 births, screened without any UK based studies, but with clearer treatment pathways. When comparing to SCD, it is possible to see correlation – a rare disease with fatal outcomes, potential long-term impact on individuals’ health, discrepancies in the incidence, and of genetic ...